Bavel, Netherlands

Rudolf Franciscus Van Beckhoven

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016-2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Rudolf Franciscus Van Beckhoven: Innovator in Peptide Technology

Introduction

Rudolf Franciscus Van Beckhoven is a notable inventor based in Bavel, Netherlands. He has made significant contributions to the field of peptide technology, particularly through his innovative methods involving water-soluble tryptophan-containing peptides. With a total of 2 patents to his name, Van Beckhoven continues to push the boundaries of scientific research and application.

Latest Patents

Van Beckhoven's latest patents focus on the production of compositions comprising water-soluble peptides derived from the hydrolysis of hen eggs lysozyme. His inventions detail a process that results in a hydrolysate with a Trp/LNAA ratio exceeding 0.15, achieved by hydrolyzing lysozyme to create a product with a degree of hydrolysis (DH) between 5 and 45. This innovative approach has potential applications in various treatment methods, showcasing the versatility and importance of his work.

Career Highlights

Throughout his career, Van Beckhoven has been associated with Dsm IP Assets B.V., where he has further developed his expertise in peptide technology. His work has not only contributed to the scientific community but has also paved the way for advancements in therapeutic applications.

Collaborations

Van Beckhoven has collaborated with esteemed colleagues such as Andre Leonardus De Roos and Luppo Edens. These partnerships have enhanced his research and innovation efforts, leading to the successful development of his patented technologies.

Conclusion

Rudolf Franciscus Van Beckhoven stands out as a prominent figure in the field of peptide technology, with his innovative methods and collaborations driving advancements in treatment applications. His contributions continue to impact the scientific community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…